Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines

Annals of Surgical Oncology

Volumn 18, Issue 6, 2011, Pages 1797-1804

  Dong, Tao Tao ^a,b,c   Zhou, Hou Min ^a,b,c   Wang, Lin Lin ^d   Feng, Bo ^a,b,c   Lv, Bo ^a,b,c   Zheng, Min Hua ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute of Digestive Surgery   (China)

^c Shanghai Minimally Invasive Surgery Center   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; OXALIPLATIN; SALINOMYCIN; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL MIGRATION; CELL MOTILITY; CELL STRAIN HT29; CELL STRAIN SW480; CELL SUBPOPULATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; COLORECTAL NEOPLASMS; DRUG THERAPY, COMBINATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; ORGANOPLATINUM COMPOUNDS; PEPTIDES; PYRANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79956202853     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1561-2     Document Type: Article

References (35)

1. CA O'Brien A Pollett S Gallinger JE Dick 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 7123 106 110 17122772 10.1038/nature05372 (Pubitemid 46067310)
2. L Ricci-Vitiani DG Lombardi E Pilozzi M Biffoni M Todaro C Peschle R De Maria 2007 Identification and expansion of human colon-cancer-initiating cells Nature 445 7123 111 115 17122771 10.1038/nature05384 1:CAS:528: DC%2BD2sXhsFOmug%3D%3D (Pubitemid 46067311)
3. P Dalerba SJ Dylla IK Park R Liu X Wang RW Cho T Hoey A Gurney EH Huang DM Simeone, et al. 2007 Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci U S A 104 24 10158 10163 17548814 10.1073/pnas.0703478104 1:CAS:528:DC%2BD2sXmvVCntLw%3D (Pubitemid 47175279)
4. K Ieta F Tanaka N Haraguchi Y Kita H Sakashita K Mimori T Matsumoto H Inoue H Kuwano M Mori 2008 Biological and genetic characteristics of tumor-initiating cells in colon cancer Ann Surg Oncol 15 2 638 648 17932721 10.1245/s10434-007-9605-3 (Pubitemid 351643025)
5. N Haraguchi M Ohkuma H Sakashita S Matsuzaki F Tanaka K Mimori Y Kamohara H Inoue M Mori 2008 CD133 + CD44 + population efficiently enriches colon cancer initiating cells Ann Surg Oncol 15 10 2927 2933 18663533 10.1245/s10434-008- 0074-0
6. S Bao Q Wu RE McLendon Y Hao Q Shi AB Hjelmeland MW Dewhirst DD Bigner JN Rich 2006 Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 7120 756 760 17051156 10.1038/nature05236 1:CAS:528:DC%2BD28Xht1OntbzP (Pubitemid 44949604)
7. M Dean T Fojo S Bates 2005 Tumour stem cells and drug resistance Nat Rev Cancer 5 4 275 284 15803154 10.1038/nrc1590 1:CAS:528:DC%2BD2MXivVarsL4%3D (Pubitemid 40488633)
8. M Diehn RW Cho NA Lobo T Kalisky MJ Dorie AN Kulp D Qian JS Lam LE Ailles M Wong, et al. 2009 Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 7239 780 783 19194462 10.1038/nature07733 1:CAS:528:DC%2BD1MXhsVCrtbc%3D
9. M Diehn 2006 Clarke MF: Cancer stem cells and radiotherapy: new insights into tumor radioresistance J Natl Cancer Inst 98 24 1755 1757 17179471 10.1093/jnci/djj505 (Pubitemid 46017927)
10. CE Eyler JN Rich 2008 Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis J Clin Oncol 26 17 2839 2845 18539962 10.1200/JCO.2007.15.1829 1:CAS:528:DC%2BD1cXotlCmsr4%3D
11. M Todaro MP Alea AB Di Stefano P Cammareri L Vermeulen F Iovino C Tripodo A Russo G Gulotta JP Medema, et al. 2007 Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 Cell Stem Cell 1 4 389 402 18371377 10.1016/j.stem.2007.08.001 1:CAS:528:DC%2BD2sXht1eku7fJ (Pubitemid 47506537)
12. PB Gupta TT Onder G Jiang K Tao C Kuperwasser RA Weinberg ES Lander 2009 Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 4 645 659 19682730 10.1016/j.cell.2009.06.034 1:CAS:528:DC%2BD1MXhsVCjs73E
13. SA Mani W Guo MJ Liao EN Eaton A Ayyanan AY Zhou M Brooks F Reinhard CC Zhang M Shipitsin, et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 4 704 715 18485877 10.1016/j.cell.2008.03.027 1:CAS:528:DC%2BD1cXmsVOru7w%3D (Pubitemid 351636299)
14. AD Yang F Fan ER Camp G van Buren W Liu R Somcio MJ Gray H Cheng PM Hoff LM Ellis 2006 Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines Clin Cancer Res 12 14 Pt 1 4147 4153 16857785 10.1158/1078-0432.CCR-06-0038 1:CAS:528:DC%2BD28XntFSmsrc%3D
15. U Wellner J Schubert UC Burk O Schmalhofer F Zhu A Sonntag B Waldvogel C Vannier D Darling A zur Hausen, et al. 2009 The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol 11 12 1487 1495 19935649 10.1038/ncb1998 1:CAS:528:DC%2BD1MXhsV2gsLnM
16. J Neuzil M Stantic R Zobalova J Chladova X Wang L Prochazka L Dong L Andera SJ Ralph 2007 Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun 355 4 855 859 17307142 10.1016/j.bbrc.2007.01.159 1:CAS:528:DC%2BD2sXivVagsr8%3D (Pubitemid 46366906)
17. TT Onder PB Gupta SA Mani J Yang ES Lander RA Weinberg 2008 Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways Cancer Res 68 10 3645 3654 18483246 10.1158/0008-5472.CAN-07-2938 1:CAS:528:DC%2BD1cXlvVOitLw%3D
18. K Polyak RA Weinberg 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 4 265 273 19262571 10.1038/nrc2620 1:CAS:528:DC%2BD1MXis1Chtb0%3D
19. Ong CW, Kim LG, Kong HH, Low LY, Iacopetta B, Soong R, Salto-Tellez M. CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Mod Pathol. 23(3):450-7.
20. S Saigusa K Tanaka Y Toiyama T Yokoe Y Okugawa Y Ioue C Miki M Kusunoki 2009 Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy Ann Surg Oncol 16 12 3488 3498 19657699 10.1245/s10434-009-0617-z
21. Artells R, Moreno I, Diaz T, Martinez F, Gel B, Navarro A, Ibeas R, Moreno J, Monzo M. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer. 2010;46(3):642-9.
22. D Corbeil K Roper A Hellwig M Tavian S Miraglia SM Watt PJ Simmons B Peault DW Buck WB Huttner 2000 The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions J Biol Chem 275 8 5512 5520 10681530 10.1074/jbc.275.8.5512 1:CAS:528:DC%2BD3cXhsFKksbk%3D (Pubitemid 30115186)
23. B Giebel D Corbeil J Beckmann J Hohn D Freund K Giesen J Fischer G Kogler P Wernet 2004 Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells Blood 104 8 2332 2338 15231568 10.1182/blood-2004-02-0511 1:CAS:528:DC%2BD2cXovVegtrY%3D (Pubitemid 39331830)
24. TM Elsaba L Martinez-Pomares AR Robins S Crook R Seth D Jackson A McCart AR Silver IP Tomlinson M Ilyas 2010 The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer PLoS One 5 5 e10714 20502714 10.1371/journal.pone.0010714
25. Rappa G FO A Lorico 2008 The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma Stem Cells 26 12 3008 3017 10.1634/stemcells.2008-0601
26. D Fuchs A Heinold G Opelz V Daniel C Naujokat 2009 Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells Biochem Biophys Res Commun 390 3 743 749 19835841 10.1016/j.bbrc.2009.10.042 1:CAS:528:DC%2BD1MXhsVKgtbbN
27. Riccioni R, Dupuis ML, Bernabei M, Petrucci E, Pasquini L, Mariani G, Cianfriglia M, Testa U. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol Dis. 2010;45(1):86-92.
28. Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun. 2010;394(4):1098-104.
29. P Yvore JP Raynaud L Conan M Naciri 1980 Evaluation of the efficacy of salinomycin in the control of coccidiosis in chicks Poult Sci 59 11 2412 2416 7465509 1:CAS:528:DyaL3MXisVymsw%3D%3D
30. TR Callaway TS Edrington JL Rychlik KJ Genovese TL Poole YS Jung KM Bischoff RC Anderson DJ Nisbet 2003 Ionophores: their use as ruminant growth promotants and impact on food safety Curr Issues Intest Microbiol 4 2 43 51 14503688 1:CAS:528:DC%2BD3sXnvVWitLw%3D (Pubitemid 37121567)
31. Li Y, Fang J, Wu S, Ma K, Li H, Yan X, Dong F. Identification and quantification of salinomycin in intoxicated human plasma by liquid chromatography-electrospray tandem mass spectrometry. Anal Bioanal Chem. 2010;398(2):955-61.
32. P Story A Doube 2004 A case of human poisoning by salinomycin, an agricultural antibiotic N Z Med J 117 1190 U799 15107902
33. Kojima M, Ishii G, Atsumi N, Nishizawa Y, Saito N, Ochiai A. CD133 expression in rectal cancer after preoperative chemoradiotherapy. Cancer Sci. 2010;101(4):906-12.
34. Y Lazebnik 2010 What are the hallmarks of cancer? Nat Rev Cancer 10 4 232 233 20355252 10.1038/nrc2827 1:CAS:528:DC%2BC3cXjtVWrsLs%3D
35. Weinberg RA. The rational treatment of cancer. In: Zayatz E, editor. The biology of cancer. New York: Garland Science; 2007. p. 787-94.